CINCINNATI--Soon after rapamycin, the first mTOR inhibitor, emerged in 1990s as a potential treatment against unwanted cell proliferation, many cancer experts had hoped emerging drugs targeting mTOR ...

Mammalian/mechanistic target of rapamycin (mTOR) signaling controls cell growth, proliferation, and metabolism in dividing cells. Less is known regarding its function in postmitotic neurons in the ...

Complicated genetic engineering may be the answer to eliminating drug resistance in leukemia patients. This cancer patient is getting a CT scan. Cancer cells pose an uncanny ability to make new cells ...